A carregar...

Tau Immunotherapies for Alzheimer’s Disease and Related Tauopathies: Progress and Potential Pitfalls.

Tau immunotherapies have now advanced from proof-of-concept studies to Phase 2 clinical trials. This review briefly outlines developments in the field and discusses how these therapies may work, which involves multiple variables that are connected in complex ways. These various factors are likely to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Alzheimers Dis
Autor principal: Sigurdsson, Einar M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6171771/
https://ncbi.nlm.nih.gov/pubmed/29865056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-179937
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!